Uniquement disponible en Anglais (US)
|
Adverse event management with cancer Immunotherapy combinations
Case-based challenges for oncologists
{{ getTitle(live) }}
{{ toDate(live.liveStartDate) }}
{{ toTime(live.liveStartDate) }} - {{ toTime(live.liveEndDate) }}
{{ getNotification(live) }}
Panel
Dr. Sandrine Aspeslagh
(UZ Brussels)
Prof. Dr. Jeroen Dekervel
(UZ Leuven)
Prof. Dr. Sylvie Rottey
(UZ Gent)
Prof. Dr. Christof Vulsteke
(UZA & Maria Middelares Gent)
Prof. Dr. Hans Prenen
(UZA)
Prof. Dr. François Duhoux
(Cliniques Universitaires Saint-Luc Bruxelles)
Prof. Dr. Karim Vermaelen
(UZ Gent)
Dr. Marco Gizzi
(Grand Hôpital de Charleroi)
R.E. Pharm Eline De Bruyne- M-BE-00000641-creation date 21/04/2021